HealthDay News — During the 2023/2024 school year, fewer US kindergarteners had complete vaccinations than in prior years, according to a study published in the October 17 issue of the US Centers for ...

HealthDay News — Annual wasteful spending on discarded lecanemab is anticipated to range between $133 and $336 million, given current vial sizes, according to a research letter published online ...

Oral semaglutide is currently approved under the brand name Rybelsus ® as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Based on these findings, ...

LNZ100 is a single-use, once-daily eye drop containing aceclidine, a small molecule acetylcholine receptor agonist that causes miosis.

HealthDay News — Women using levonorgestrel-releasing intrauterine systems (LNG-IUS) have an increased risk for breast cancer, according to a study published online October 16 in the Journal of the ...

Botox Cosmetic is also indicated for the temporary improvement in appearance of moderate to severe glabellar lines, lateral canthal lines, and forehead lines. The product is supplied as 50 units and ...

On October 7, a compounding trade group filed a lawsuit challenging the agency's action, saying there was still a shortage of ...

Nonlinear association seen for effective castration period with metastasis-free survival for any ADT duration.

The policy confused patients and physicians, with patients not knowing whether their message would require more than 5 minutes of a clinician's time and physicians unsure about how to handle ...

Findings showed no increased risk of pregnancy, birth, or neonatal/infant outcomes with Flublok compared with standard-dose flu vaccine and estimated pregnancy outcomes for the general population.

The researchers found that 1,188,277 deaths could potentially be prevented over 12 months with optimal implementation of quadruple GDMT. (HealthDay News) — For individuals with heart failure ...

Marstacimab is a human monoclonal immunoglobulin G type 1 antibody that enhances coagulation by targeting the Kunitz 2 domain of tissue factor pathway inhibitor.